Chronic ethanol consumption up-regulates protein-tyrosine phosphatase-1B (PTP1B) expression in rat skeletal muscle. 2010

Li GAO, and Xu ZHANG, and Fu-rong WANG, and Ming-feng CAO, and Xiu-juan ZHANG, and Nan-nan SUN, and Jie ZHANG, and Ling GAO, and Jia-jun ZHAO
Department of Endocrinology, Provincial Hospital affiliated to Shandong University, Institute of Endocrinology, Shandong Academy of Clinical Medicine, Ji-nan 250021, China.

OBJECTIVE to investigate the potential effects of chronic ethanol intake on protein-tyrosine phosphatase-1B (PTP1B) and the insulin receptor signaling pathway in rat skeletal muscle. METHODS rats received ethanol treatment at a daily dose of 0 (control), 0.5 (group L), 2.5 (group M) or 5 gxkg(-1) (group H) via gastric gavage for 22 weeks. In vivo insulin sensitivity was measured using a hyperinsulinemic-euglycemic clamp. Expression of PTP1B in skeletal muscles was examined at both the mRNA (real-time PCR) and protein (Western blot) levels. PTP1B activity was assayed with a p-nitrophenol phosphate (PNPP) hydrolysis method. Changes of insulin signaling in skeletal muscle were analyzed with Western blotting. RESULTS the activity and expression of PTP1B were dose-dependently elevated 1.6 and 2.0 fold in the skeletal muscle by ethanol, resepctively, at the doses of 2.5 and 5 gxkg(-1)xd(-1). Total IRβ and IRS-1, as well as their phosphorylated forms, were decreased by ethanol at the two higher doses. Moreover, chronic ethanol consumption resulted in a significant inhibition of the association between IRS-1 and the p85 subunit of phosphatidylinositol 3-kinase, inhibition of Akt phosphorylation and reduced levels of mitogen-activated protein kinase phosphorylation. CONCLUSIONS chronic ethanol intake at 2.5 and 5 xkg(-1)xd(-1) sufficient doses can down-regulate the expression of IRβ, P-IRβ, and IRS-1, as well as the phosphorylated forms of IRS-1 and Akt, in rat skeletal muscle, possibly through increased PTP1B activity.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

Li GAO, and Xu ZHANG, and Fu-rong WANG, and Ming-feng CAO, and Xiu-juan ZHANG, and Nan-nan SUN, and Jie ZHANG, and Ling GAO, and Jia-jun ZHAO
February 2011, Inflammation,
Li GAO, and Xu ZHANG, and Fu-rong WANG, and Ming-feng CAO, and Xiu-juan ZHANG, and Nan-nan SUN, and Jie ZHANG, and Ling GAO, and Jia-jun ZHAO
June 2012, Diabetes,
Li GAO, and Xu ZHANG, and Fu-rong WANG, and Ming-feng CAO, and Xiu-juan ZHANG, and Nan-nan SUN, and Jie ZHANG, and Ling GAO, and Jia-jun ZHAO
January 2013, Vitamins and hormones,
Li GAO, and Xu ZHANG, and Fu-rong WANG, and Ming-feng CAO, and Xiu-juan ZHANG, and Nan-nan SUN, and Jie ZHANG, and Ling GAO, and Jia-jun ZHAO
January 2003, Current topics in medicinal chemistry,
Li GAO, and Xu ZHANG, and Fu-rong WANG, and Ming-feng CAO, and Xiu-juan ZHANG, and Nan-nan SUN, and Jie ZHANG, and Ling GAO, and Jia-jun ZHAO
April 2005, The Journal of biological chemistry,
Li GAO, and Xu ZHANG, and Fu-rong WANG, and Ming-feng CAO, and Xiu-juan ZHANG, and Nan-nan SUN, and Jie ZHANG, and Ling GAO, and Jia-jun ZHAO
April 2009, Journal of ophthalmic & vision research,
Li GAO, and Xu ZHANG, and Fu-rong WANG, and Ming-feng CAO, and Xiu-juan ZHANG, and Nan-nan SUN, and Jie ZHANG, and Ling GAO, and Jia-jun ZHAO
November 2004, Bioorganic & medicinal chemistry letters,
Li GAO, and Xu ZHANG, and Fu-rong WANG, and Ming-feng CAO, and Xiu-juan ZHANG, and Nan-nan SUN, and Jie ZHANG, and Ling GAO, and Jia-jun ZHAO
April 2011, The American journal of pathology,
Li GAO, and Xu ZHANG, and Fu-rong WANG, and Ming-feng CAO, and Xiu-juan ZHANG, and Nan-nan SUN, and Jie ZHANG, and Ling GAO, and Jia-jun ZHAO
January 2017, Frontiers in aging neuroscience,
Li GAO, and Xu ZHANG, and Fu-rong WANG, and Ming-feng CAO, and Xiu-juan ZHANG, and Nan-nan SUN, and Jie ZHANG, and Ling GAO, and Jia-jun ZHAO
January 2022, Current cancer drug targets,
Copied contents to your clipboard!